Human iPSC-based breast cancer model identifies S100P-dependent cancer stemness induced by BRCA1 mutation

基于人诱导多能干细胞的乳腺癌模型揭示了BRCA1突变诱导的S100P依赖性癌症干性

阅读:3
作者:Jingxin Liu,Cai Zhao,Jiahao Chen,Pengguihang Zeng,Qingjian Li,Ranran Dai,Xingqiang Lai,Wenqian Song,Jianing Chen,Xixi Zhu,Xinyi Liu,Jun Sun,Jia Wang,Peihang Fang,Tengfei Wang,Wenjie Chen,Diana Guallar,Nan Cao,Jianli Zhao,Shicheng Su,Andy Peng Xiang,Yi Arial Zeng,Jie Li,Junchao Cai,Dung-Fang Lee,Jinxin Bei,Yongliang Huo,Hai Hu,Shengbao Suo,Dong-Feng Huang,Jin Bai,Junjun Ding

Abstract

Breast cancer is the most common malignancy in females and remains the leading cause of cancer-related deaths for women worldwide. The cellular and molecular basis of breast tumorigenesis is not completely understood partly due to the lack of human research models which simulate the development of breast cancer. Here, we developed a method for generating functional mammary-like cells (MCs) from human-induced pluripotent stem cells (iPSCs). The iPSC-MCs closely resemble human primary MCs at cellular, transcriptional, and functional levels. Using this method, a breast cancer model was generated using patient-derived iPSCs harboring germline BRCA1 mutation. The patient iPSC-MCs recapitulated the transcriptome, clinical genomic alteration, and tumorigenic ability of breast cancer cells. We also identified S100P as an oncogene downstream of mutated BRCA1 that promotes cancer cell stemness and tumorigenesis. Our study establishes a promising system of breast cancer for studying the mechanism of tumorigenesis and identifying potential therapeutic targets.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。